LACOSAMID Mepha Lactab 50 mg 14 pce
7680676300012
CH-67630
N03AX18
01.07.1.
Reimbursement limitations:
VIMPAT
En association dans le traitement des crises partielles avec ou sans généralisation secondaire chez des …
1 / 3
google
Details
- Product number
- 6763001
- CPT
- -
- Packaging group
- 14
- Unit
- Tablette(n)
- Composition
- Filmtablette: lacosamidum 50 mg, cellulosum microcristallinum, hydroxypropylcellulosum, silica colloidalis anhydrica, crospovidonum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, E 171, E 172 (rubrum), E 172 (nigrum), E 172 (flavum), pro compresso obducto.
Articles (1)
Lacosamid-Mepha 50 mg, Filmtabletten
Filmtabletten
14
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
FTAB
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | FNIDK |
|
FTAB
|
- | Substance | FTODK |
|
FTAB
|
- | Substance | FTODK |
|
FTAB
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 13.65
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/04/2022
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 67630
- Drug name
- Lacosamid-Mepha, Filmtabletten
- Galenic form
- FILM
- ATC Code
- N03AX18
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 26/06/2021
- Authorization expiration date
- 25/06/2026
- IT number
- 01.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LACOSAMID Mepha Lactab 50 mg 14 pce
- Description (DE)
- LACOSAMID Mepha Lactab 50 mg 14 Stk
- Market launch
- 26/06/2021
- Narcotic (BTM)
- No